Satellite Banner
Technology Networks Header
Tuesday, September 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
Friday, September 12, 2014
Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices.

Meet SeedEZ, a universal 3D cell culture drug screening system
Sunday, September 07, 2014
Lena Biosciences introduces a robust and easy to use SeedEZ 3D cell culture drug screening system supporting consistent yet complex 3D cell culture, co-culture and multilayered tissue models with immune and inflammatory components.

Easy-to-use, Quantitative Gamma-H2AX Assay
Tuesday, September 02, 2014
Gamma H2AX pharmacodynamic assay kit for the study of double strand DNA breaks.

Versatile Range of Horizontal Gel Electrophoresis Units
Tuesday, September 02, 2014
Cleaver MultiSUB™ gel electrophoresis range for low- and high-throughput DNA and RNA applications.

Onxeo Strengthens Beleodaq® Patent Protection in the U.S. Until 2027
Friday, August 29, 2014
U.S. Patent will be granted on September 16th 2014.

Next-Generation Assay Platform Expands Cell Analysis for Life Science Researchers
Monday, August 18, 2014
The Countess II FL cell-counting instrument’s modular design broadens the number of applications possible.

Bioo Scientific First to Address Small RNA-Seq Bias Concerns
Wednesday, August 13, 2014
Company launches NEXTflex™ Small RNA Sequencing Kit v2.

Cancer Conference Poster Prize Winner Announced
Monday, August 11, 2014
Katarzyna Grzes, winner of the AMSBIO-Trevigen prize for the best poster, is a PhD researcher specialising in Cell Signaling and Immunology.

Merck Millipore Introduces Magna™ Nuclear RIP Kits
Tuesday, August 05, 2014
Facilitates isolation and analysis of RNA molecules associated with chromatin.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 651
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv